PET Imaging Study Using Evuzamitide to Detect Cardiac Amyloidosis in Patients With Inconclusive Nuclear Scans and Elevated TAD1 Levels

NCT07538518 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Amyloidogenic Transthyretin (ATTR) Amyloidosis
Cardiac Amyloidosis

Interventions

DRUG: Evuzamitide

Sponsor

Lorena Saelices

Collaborators

[object Object]